Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
the Challenge Programme of the Novo Nordisk Foundation: “Mathematical Modelling for Microbial Community Induced Metabolic Diseases”, led by Prof. Daniel Merkle. The expected starting date is 1 Januar 2026, with
-
. The Department of Mathematics and Computer Science, Hessain.AI research group “Artificial Intelligence – Deep Decision Support Systems”, led by Prof. Dr. Martin Becker, is currently accepting applications for a
-
diverse academic backgrounds to contribute to our projects in areas such as: Network Security, Information Assurance, Model-driven Security, Cloud Computing, Cryptography, Satellite Systems, Vehicular
-
St. Jude is seeking outstanding candidates for postdoctoral fellowship positions in the Childhood Hematological Malignancies Training Program. This prestigious, NIH-sponsored T32 training program
-
NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and the
-
once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to August 2028 Closing date: 25th July 2025 Background We are seeking an innovative Research Fellow in Computational Metabolomics
-
mechanisms linking cardiovascular diseases with cancer and cancer therapies. She uses human-induced pluripotent stem cells (iPSCs), patient-derived samples, genomics, and computational biology to identify
-
A Postdoctoral Research Associate or more senior research position in computational biology is available in the Pritykin lab at the Lewis-Sigler Institute for Integrative Genomics and the
-
We are seeking a highly motivated and creative candidate for a fully supported postdoctoral fellowship to develop immune-based therapies. Specifically, the research is aimed to develop cell-based immunotherapies for pediatric tumors. Studies are focused on using genetic engineering approaches to...
-
The newly established Program for Memory Longevity (PML), led by Attila Losonczy, MD, PhD, in the O’Donnell Brain Institute (OBI) and the Department of Neuroscience at the University of Texas